Results 251 to 260 of about 232,710 (307)

Time to Nadir PSA

American Journal of Clinical Oncology, 2015
The objective of the study was to investigate prostate-specific antigen (PSA) nadir (nPSA) and time to nPSA (TnPSA) as prognostic variables for outcomes after definitive high-dose (>75 Gy) external beam radiation therapy (RT) without androgen deprivation therapy while correcting for immortal-time bias.nPSA and TnPSA were available for 410 patients ...
Skyler B, Johnson, William C, Jackson, Jure, Murgic, Felix Y, Feng, Daniel A, Hamstra   +4 more
openaire   +2 more sources

Standardization of PSA determinations

Scandinavian Journal of Clinical and Laboratory Investigation, 1995
Standardization of determinations for prostate specific antigen (PSA) has become an important issue due to the widespread use of these determinations for prostate cancer screening. Standardization of this assay is complicated due to the occurrence of two major forms of PSA in serum, the free antigen and a complex between PSA and alpha 1 ...
U H, Stenman, J, Leinonen, W M, Zhang
openaire   +2 more sources

Natural history of progression after PSA elevation following radical prostatectomy.

Journal of the American Medical Association (JAMA), 1999
C. Pound, A. Partin, M. Eisenberger, Daniel W. Chan, J. Pearson, P. Walsh   +5 more
semanticscholar   +1 more source

Efforts for Improving the Efficiency of PSA: PSA Density, PSA Velocity, Age-specific PSA, and Free and Complexed PSA

Türk Üroloji Seminerleri/Turkish Urology Seminars, 2013
Omer Kutlu, Ismail Turker Koksal
openaire   +1 more source

Ground-Motion Prediction Equations for the Average Horizontal Component of PGA, PGV, and 5%-Damped PSA at Spectral Periods between 0.01 s and 10.0 s

, 2008
D. Boore, G. Atkinson
semanticscholar   +1 more source

68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour

European Journal of Nuclear Medicine and Molecular Imaging, 2017
C. Uprimny, A. Kroiss, C. Decristoforo, J. Fritz, E. von Guggenberg, D. Kendler, L. Scarpa, Gianpaolo di Santo, Llanos Geraldo Roig, Johanna Maffey-Steffan, W. Horninger, I. Virgolini   +11 more
semanticscholar   +1 more source

Impedimetric aptamer-based glycan PSA score for discrimination of prostate cancer from other prostate diseases

Biosensors and Bioelectronics, 2021
Estrela Pedro, Rebeca Miranda-Castro, Ana Díaz-Fernández   +2 more
exaly  

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate Cancer and Prostatic Diseases, 2017
T. Nordström, O. Akre, M. Aly, H. Grönberg, M. Eklund   +4 more
semanticscholar   +1 more source

Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.

Cancer Letters, 2017
M. Logozzi, D. Angelini, Elisabetta Iessi, D. Mizzoni, R. Di Raimo, C. Federici, L. Lugini, G. Borsellino, A. Gentilucci, Federico Pierella, V. Marzio, A. Sciarra, L. Battistini, S. Fais   +13 more
semanticscholar   +1 more source

Treatment Outcomes from 68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET

Journal of Nuclear Medicine, 2017
L. Emmett, P. V. van Leeuwen, Rohan Nandurkar, M. Scheltema, T. Cusick, G. Hruby, A. Kneebone, T. Eade, G. Fogarty, R. Jagavkar, Quoc Nguyen, B. Ho, A. Joshua, P. Stricker   +13 more
semanticscholar   +1 more source